全文获取类型
收费全文 | 3150篇 |
免费 | 165篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 94篇 |
妇产科学 | 80篇 |
基础医学 | 527篇 |
口腔科学 | 38篇 |
临床医学 | 238篇 |
内科学 | 833篇 |
皮肤病学 | 41篇 |
神经病学 | 407篇 |
特种医学 | 88篇 |
外科学 | 237篇 |
综合类 | 9篇 |
预防医学 | 161篇 |
眼科学 | 33篇 |
药学 | 215篇 |
中国医学 | 10篇 |
肿瘤学 | 313篇 |
出版年
2024年 | 8篇 |
2023年 | 29篇 |
2022年 | 56篇 |
2021年 | 98篇 |
2020年 | 54篇 |
2019年 | 61篇 |
2018年 | 106篇 |
2017年 | 79篇 |
2016年 | 72篇 |
2015年 | 100篇 |
2014年 | 117篇 |
2013年 | 168篇 |
2012年 | 244篇 |
2011年 | 235篇 |
2010年 | 131篇 |
2009年 | 140篇 |
2008年 | 238篇 |
2007年 | 226篇 |
2006年 | 210篇 |
2005年 | 190篇 |
2004年 | 207篇 |
2003年 | 152篇 |
2002年 | 145篇 |
2001年 | 30篇 |
2000年 | 17篇 |
1999年 | 28篇 |
1998年 | 34篇 |
1997年 | 32篇 |
1996年 | 24篇 |
1995年 | 10篇 |
1994年 | 19篇 |
1993年 | 16篇 |
1992年 | 16篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1989年 | 5篇 |
1988年 | 7篇 |
1987年 | 7篇 |
1986年 | 6篇 |
1985年 | 4篇 |
1984年 | 4篇 |
1983年 | 4篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有3342条查询结果,搜索用时 31 毫秒
21.
22.
Genetic instability in superficial bladder cancer and adjacent mucosa: an interphase cytogenetic study 总被引:5,自引:0,他引:5
Cianciulli AM Leonardo C Guadagni F Marzano R Iori F De Nunzio C Franco G Merola R Laurenti C 《Human pathology》2003,34(3):214-221
A systematic analysis of both tumors and the surrounding urothelium to help identify what lies behind the mechanism of multifocal tumor development has not yet been performed. In this study we investigated chromosome 1, 7, 9, and 17 aneusomy in 25 superficial papillary carcinomas and in 51 tissue samples taken from sites of macroscopically uninvolved urothelium surrounding the tumors, using the fluorescence in situ hybridization method. Our data demonstrated a close genetic relationship between all examined tumors and normal-appearing mucosa. Numeric aberrations of chromosomes 1, 7, 9, and 17 were found to exhibit similar patterns in all analyzed specimens, although with different frequencies. 相似文献
23.
24.
Mariella Dono Simona Zupo Raffaella Masante Giuseppe Taborellin Nicholas Chiorazzp Manlio Ferrarini 《European journal of immunology》1993,23(4):873-881
This study investigated the response of different CD5? B cell subsets to CD40 monoclonal antibody (mAb) in various combinations with interleukin (IL)-4 or rabbit anti-human μ chain antibody (a-μ-Ab). The different CD5 B cell subsets were isolated from tonsillar B cell suspensions depleted of CD5+ B cells and subsequently fractionated on Percoll density gradients. While resting CD5+ B cells proliferated and produced IgM molecules in response to a-μ-Ab, IL-4 and CD40 mAb as well as to Staphylococcus aureus Cowan strain I (SAC) and IL-2, resting CD5? B cells, which were co-purified in the same 60% Percoll fractions, consistently failed to respond. These cells were, however, activated by the stimuli employed, as demonstrated by their capacity to express the surface activation markers CD69, CD25 and CD71. Resting CD5+ B cells had the typical phenotype of mantle zone B cells (IgM+ IgD+ CD39+ CD38? CD10? CDw75dim), whereas resting CD5? B cells were CD38? CD39? CD 10? CDw75 intermediate and expressed surface IgM but relatively little surface IgD and could not be classified as mantle zone or germinal center cells. The finding that purified germinal center cells (CD38+ CD10+ CD39? CDw75bright, IgG+) responded to CD40 mAb and IL-4 and also to SAC plus IL-2 further underlined the differences to resting CD5? B cells. However, some of the data collected suggest possible relationships between CD5? B cells and germinal center cells. The CD5? B cells isolated from the 50 % Percoll fraction proliferated in response to a-μ-Ab, CD40 mAb and IL-4 as well as to SAC and IL-2. These cells had the same mantle zone B cell phenotype as the CD5+ B cells, but their capacity to respond to the stimuli in vitro was unrelated to a possible contamination with CD5+ B cells, as documented by the appropriate controls. Furthermore, upon exposure to SAC or phorbol esters, the large majority of CD5? B cells from the 50 % Percoll fraction did not express surface CD5 and there was very little if any accumulation of CD5 mRNA. Finally, most of the cycling cells in the stimulated CD5? B cells did not express CD5. The CD5? B cells from the 50 % Percoll fraction were comprised of a consistent proportion of cells that expressed surface activation markers. The removal of these cells abrogated the capacity of the suspensions to respond to the stimuli in vitro, possibly suggesting that these cells additional activation signals in vivo which were essential to acquire the capacity to respond and that could not be reproduced in vitro. The present study underlines the phenotypic and functional heterogeneity of CD5? B cells and contributes to the identification of two subsets of these cells which differ in phenotype, tissue distribution and in vitro responses to different stimuli. 相似文献
25.
Mariano Rocchi Angela Covone Giovanni Romeo Raffaella Faraonio Vittorio Colantuoni 《Somatic Cell and Molecular Genetics》1989,15(2):185-190
The human gene coding for RBP4 has been assigned to 10q2324 using a panel of somatic cell hybrids and in situ hybridization experiments. The mapping of the human RBP1, previously assigned by our group to chromosome 3 using a panel of somatic cell hybrids, was restricted to the region 3q2122 using in situ experiments and Southern blots of genomic DNA from a hybrid retaining a portion of chromosome 3.R.F. is recipient of a Research Grant from A.I.R.C. 相似文献
26.
Laura Masi Raffaella Recenti Sandra Silvestri Pamela Pinzani Monica Pepi Milena Paglierani Maria Luisa Brandi Alessandro Franchi 《Applied immunohistochemistry & molecular morphology》2007,15(1):70-76
Several studies indicate that cyclooxygenase-2 (COX-2) is overexpressed in human malignancies, where it produces high levels of prostaglandins and contributes to tumor growth. In this study we have analyzed the expression of COX-2 in a series of 48 skeletal osteosarcomas of different subtypes by immunohistochemistry. In addition, we examined the effects of the specific COX-2 inhibitor Celecoxib on the growth of the human osteosarcoma cell line SaOS-2. Immunoreactivity for COX-2 was observed in 39 out of 48 tumors (81.2%), 30 (76.9%) of which showed a moderate or diffuse immunostaining. Considering the group of 42 primary osteosarcomas, COX-2 immunoreactivity was significantly higher in high grade osteosarcomas, where moderate or diffuse expression was detected in 23 out of 32 cases (71.8%), than in low grade osteosarcomas, where moderate or diffuse expression was detected in 2 out of 10 cases (20%) (P = 0.008, Fisher exact test). In addition, low COX-2 expression was always associated with a good response to chemotherapy (5 out of 5 cases), whereas moderate or diffuse COX-2 expression was associated with a good response in 11 out of 20 cases (55%) (P = 0.12, Fisher exact test). In SaOS-2 osteosarcoma cells, which express COX-2, treatment with Celecoxib determined inhibition of cell proliferation and induction of apoptosis. These results indicate that COX-2 is expressed at high levels in high grade osteosarcomas and support the use of COX-2 inhibitors to improve both the tumor response to chemotherapy and the outcome of osteosarcoma patients. 相似文献
27.
28.
Tardito D Mori S Racagni G Smeraldi E Zanardi R Perez J 《Journal of affective disorders》2003,76(1-3):249-253
BACKGROUND: Abnormal levels of protein kinase A (PKA) were found in patients with bipolar disorder (BD). Since altered levels are generally accompanied by functional modifications, the purpose of this study was to investigate PKA activity in patients with BD. METHODS: PKA activity was assessed in platelets from 20 drug-free bipolar patients and 19 controls. RESULTS: The cAMP-stimulated PKA activity was significantly increased in bipolar patients compared with controls. LIMITATIONS: This study made use of platelets, which may not fully represent changes occurring in specific brain regions. CONCLUSION: This study adds to the growing evidence suggesting that abnormalities of PKA are associated with BD. 相似文献
29.
Stolina M Guo J Faggioni R Brown H Senaldi G 《Clinical immunology (Orlando, Fla.)》2003,109(3):347-354
The interaction between receptor activator of nuclear factor-kappaB ligand (RANKL) and RANK has been reported to regulate immunity in addition to bone metabolism. The aim of this study was to determine if osteoprotegerin (OPG), an inhibitor of the RANKL-RANK interaction and possibly a new drug against osteoporosis, would adversely affect immunity. OPG was used to treat mice developing different models of cellular and humoral immune responses and also in vitro in T and B cell assays. In mice, OPG does not affect cell-mediated reactions such as contact hypersensitivity to the hapten oxazolone and liver damage, granuloma formation, and infectious load induced by mycobacterial infection. However, OPG increases humoral reactions such as the production of IgM, IgG, and IgE against the T cell dependent antigen keyhole limpet hemocyanin and the production of IgM against the T cell independent antigen Pneumovax. In vitro, OPG modestly co-stimulates T cells but does not affect the proliferation of B cells. OPG has modest immunoregulatory effects that seem to be confined to the humoral response to specific antigens. 相似文献
30.
Silvano Ferrini Anna Cambiaggi Raffaella Meazza Sabrina Sforzini Sabrina Marciano Maria Cristina Mingari Lorenzo Moretta 《European journal of immunology》1994,24(10):2294-2298
A new anti-p58 monoclonal antibody (mAb), termed CH-L, has been used to characterize a minor subset of T lymphocytes co-expressing p58 and CD3 molecules. In two-color immunofluorescence analysis, CH-L+CD3+ cells represented 0.5 to 6% of the peripheral blood lymphocytes (in 20 healthy donors). Clonal analysis showed that most CD3+CH-L+ T cell clones expressed the CD8+4? T cell receptor (TcR) α/β+ phenotype, while only a few were CD8?4+ TcR α/β+, CD8?4? TcR α/β+ or CD8?4? TcR γ/δ+. Western blot analysis indicated that the CH-L mAb identifies the same 56-58-kDa diffuse band in both T and natural killer cell (NK) clones. A minority of T cell clones also expressed other NK-related markers such as CD16, CD56 and CD94 and two clones also reacted with the anti-p58 mAb EB6. Interestingly, most clones displayed cytolytic activity in an anti-CD3 mAb-triggered redirected killing assay against the Fcδ receptor+ P815 target cells and NK-like activity against K562 and Raji cells. In contrast, the IGROV-1 ovarian carcinoma cell line was resistant to cytolysis by all of these clones. Since p58 molecules have previously been shown to exert regulatory functions on NK-mediated lysis, we investigated whether anti-p58 mAb could also influence cytotoxicity mediated by CD3+p58+ T lymphocytes. Lysis of P815 target cells, triggered by anti-CD3 mAb, could be inhibited by anti-p58 mAb in 8 out of 12 cytolytic clones tested, while 4 clones were not inhibited. In addition, anti-p58 mAb enhanced the cytolytic activity of 3 clones against IGROV-1 and of 4 other clones against Raji target cells. Taken together, these data indicate that p58+ T cells express heterogeneous phenotypes and different forms of TcR and, in most instances, display cytolytic functions. Perhaps more importantly, the p58 molecule appears to modulate the cytolytic activity triggered via the CD3/TcR complex. 相似文献